Matsuhashi N - Search Results

1

Adiponectin-expressing Treg-containing T cell fraction inhibits tumor growth in orthotopically implanted triple-negative breast cancer.

Chikaishi W, Higashi T, Hayashi H, Hanamatsu Y, Futamura M, Matsuhashi N, Saigo C, Takeuchi T. Chikaishi W, et al. Among authors: matsuhashi n. Thorac Cancer. 2023 Oct;14(30):3058-3062. doi: 10.1111/1759-7714.15102. Epub 2023 Sep 6. Thorac Cancer. 2023. PMID: 37674354 Free PMC article.

2

Positive feedback of DDX6/c-Myc/PTB1 regulated by miR-124 contributes to maintenance of the Warburg effect in colon cancer cells.

Taniguchi K, Sugito N, Kumazaki M, Shinohara H, Yamada N, Matsuhashi N, Futamura M, Ito Y, Otsuki Y, Yoshida K, Uchiyama K, Akao Y. Taniguchi K, et al. Among authors: matsuhashi n. Biochim Biophys Acta. 2015 Sep;1852(9):1971-80. doi: 10.1016/j.bbadis.2015.06.022. Epub 2015 Jul 2. Biochim Biophys Acta. 2015. PMID: 26144048 Free article.

3

Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status.

Kato J, Futamura M, Kanematsu M, Gaowa S, Mori R, Tanahashi T, Matsuhashi N, Yoshida K. Kato J, et al. Among authors: matsuhashi n. Int J Cancer. 2016 Mar 15;138(6):1516-27. doi: 10.1002/ijc.29881. Epub 2015 Oct 23. Int J Cancer. 2016. PMID: 26437179 Free PMC article.

4

MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1.

Sugiyama T, Taniguchi K, Matsuhashi N, Tajirika T, Futamura M, Takai T, Akao Y, Yoshida K. Sugiyama T, et al. Among authors: matsuhashi n. Cancer Sci. 2016 Dec;107(12):1767-1775. doi: 10.1111/cas.13091. Epub 2016 Dec 19. Cancer Sci. 2016. PMID: 27696637 Free PMC article.

5

Computed tomograpy evaluation of morphological changes, clinical response and survival in colorectal cancer liver metastasis treated by regorafenib: A case report.

Matsuhashi N, Takahashi T, Kato J, Tanahashi T, Matsui S, Sasaki Y, Imai H, Tanaka Y, Okumura N, Yamaguchi K, Futamura M, Osada S, Yoshida K. Matsuhashi N, et al. Mol Clin Oncol. 2016 Dec;5(6):807-810. doi: 10.3892/mco.2016.1045. Epub 2016 Oct 5. Mol Clin Oncol. 2016. PMID: 28105361 Free PMC article.

6

Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer.

Tajima JY, Futamura M, Gaowa S, Mori R, Tanahashi T, Tanaka Y, Matsuhashi N, Takahashi T, Yamaguchi K, Miyazaki T, Yoshida K. Tajima JY, et al. Among authors: matsuhashi n. J Cancer. 2018 Jan 1;9(2):358-366. doi: 10.7150/jca.20266. eCollection 2018. J Cancer. 2018. PMID: 29344282 Free PMC article.

7

DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells.

Tajirika T, Tokumaru Y, Taniguchi K, Sugito N, Matsuhashi N, Futamura M, Yanagihara K, Akao Y, Yoshida K. Tajirika T, et al. Among authors: matsuhashi n. Int J Mol Sci. 2018 Jul 9;19(7):2005. doi: 10.3390/ijms19072005. Int J Mol Sci. 2018. PMID: 29987267 Free PMC article.

8

Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.

Tokumaru Y, Tajirika T, Sugito N, Kuranaga Y, Shinohara H, Tsujino T, Matsuhashi N, Futamura M, Akao Y, Yoshida K. Tokumaru Y, et al. Among authors: matsuhashi n. Int J Mol Sci. 2019 Apr 5;20(7):1697. doi: 10.3390/ijms20071697. Int J Mol Sci. 2019. PMID: 30959742 Free PMC article.

9

Combination chemotherapy with TAS-102 plus bevacizumab in salvage-line treatment of metastatic colorectal cancer: A single-center, retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage-line therapy of metastatic colorectal cancer.

Matsuhashi N, Takahashi T, Fujii H, Suetsugu T, Fukada M, Iwata Y, Tokumaru Y, Imai T, Mori R, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K, Futamura M, Yoshida K. Matsuhashi N, et al. Mol Clin Oncol. 2019 Oct;11(4):390-396. doi: 10.3892/mco.2019.1899. Epub 2019 Jul 18. Mol Clin Oncol. 2019. PMID: 31475067 Free PMC article.

10

KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.

Tokumaru Y, Oshi M, Katsuta E, Yan L, Satyananda V, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. Tokumaru Y, et al. Among authors: matsuhashi n. Am J Cancer Res. 2020 Mar 1;10(3):897-907. eCollection 2020. Am J Cancer Res. 2020. PMID: 32266098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters